In a case before the Wisconsin Supreme Court that seeks to force physicians to provide substandard care, the American Medical Association (AMA) and Wisconsin Medical Society (WisMed) today filed an amicus brief (PDF) arguing against ivermectin as a court ordered intervention for COVID-19 as the drug has not proven effective against the disease.
The amicus brief in Gahl v. Aurora Health notes that ivermectin is not within the standard of care for the treatment of COVID-19 and warned against the court compelling the use of a drug that medical consensus finds is unsupported by available medical evidence and discouraged by federal agencies and health authorities.
The U.S. Centers for Disease Control & Prevention and the Food & Drug Administration have issued advisories indicating that ivermectin is not authorized or approved for the prevention or treatment of COVID-19. While the National Institutes of Health, World Health Organization, and Merck—the manufacturer of ivermectin—all state there is insufficient evidence to support the use of ivermectin to treat COVID-19.
The AMA and WisMed stated in the brief, “The overwhelming majority of studies investigating ivermectin have not found it to be an effective COVID-19 treatment. The few dissenting studies that exist have ‘substantially evaporated under close scrutiny’ and even ivermectin’s manufacturer ‘do[es] not believe that the data available support the safety and efficacy of ivermectin for preventing or treating COVID-19. Thus, the consensus view of reasonable medical providers is that, apart from clinical trials, ivermectin should not be administered to treat COVID-19.”
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.